We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

73 hedge funds and large institutions have $196M invested in MyoKardia, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

3% more funds holding

Funds holding: 71 → 73 (+2)

0% more capital invested

Capital invested by funds: $195M → $196M (+$503K)

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
27
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.29M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.48M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.58M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.51M
5
TC
TFS Capital
Pennsylvania
+$910K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.97M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.04M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.57M
4
SFM
Sphera Funds Management
Israel
-$1.08M
5
Norges Bank
Norges Bank
Norway
-$869K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$575K +$30.7K +2,394 +6%
FIM
27
Fernwood Investment Management
Massachusetts
$570K +$4.19K +327 +0.8%
Victory Capital Management
28
Victory Capital Management
Texas
$533K +$171K +13,355 +49%
TI
29
Trexquant Investment
Connecticut
$500K +$279K +21,787 +134%
HLA
30
Hamilton Lane Advisors
Pennsylvania
$490K +$198K +15,433 +71%
TCIM
31
TIAA CREF Investment Management
New York
$453K -$88.4K -6,900 -17%
Deutsche Bank
32
Deutsche Bank
Germany
$427K +$318K +24,821 +321%
PIM
33
Partner Investment Management
California
$407K -$19.7K -1,539 -5%
FT
34
Fiduciary Trust
Massachusetts
$375K – – –
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$341K -$7.69K -600 -2%
JRP
36
Jasper Ridge Partners
California
$338K +$329K +25,686 New
Swiss National Bank
37
Swiss National Bank
Switzerland
$333K – – –
TA
38
Teachers Advisors
New York
$288K -$80K -6,244 -22%
VEA
39
Virtus ETF Advisers
New York
$275K +$25.6K +2,002 +11%
AAM
40
Aberdeen Asset Management
United Kingdom
$270K +$121K +9,451 +85%
DTL
41
Dynamic Technology Lab
Singapore
$269K +$262K +20,458 New
Morgan Stanley
42
Morgan Stanley
New York
$262K -$253K -19,760 -50%
Wells Fargo
43
Wells Fargo
California
$238K -$280K -21,839 -55%
HTC
44
Hershey Trust Company
Pennsylvania
$209K +$110K +8,562 +116%
DSI
45
Daiwa SB Investments
Japan
$170K +$166K +12,965 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$167K +$11K +858 +7%
HHC
47
Hutchin Hill Capital
New York
$156K +$152K +11,900 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$154K +$13 +1 +0%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$143K +$14.6K +1,143 +12%
HCM
50
Highbridge Capital Management
New York
$136K +$132K +10,338 New
1
2
3 4

MYOK Hedge Fund Activity: Q1 2017 in Review

73 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q1 2017, worth a combined $196M — up 0.26% from $195M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MYOK positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $8.29M. The largest seller was Fidelity Investments, cutting an estimated $7.97M.

  • 73 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q1 2017, up from 71 in Q4 2016.
  • Funds reported $196M of MyoKardia, Inc. Common Stock stock for Q1 2017, up 0.26% quarter-over-quarter.
  • 17 funds opened new MyoKardia, Inc. Common Stock positions in Q1 2017 and 10 closed out, a net change of +7 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $8.29M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q1 2017 was Fidelity Investments, an estimated $7.97M sold.

Based on aggregated 13F filings for Q1 2017.